
---
title: '恒瑞医药：药品SHR6508注射液获得药物临床试验批准通知书'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=2431'
author: 36kr
comments: false
date: Fri, 09 Jul 2021 08:57:03 GMT
thumbnail: 'https://picsum.photos/400/300?random=2431'
---

<div>   
36氪获悉，恒瑞医药公告称，子公司药品SHR6508注射液获得药物临床试验批准通知书。  
</div>
            